Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Anil Ocak"'
Autor:
Mahir Karakas, Ibrahim Akin, Christoph Burdelski, Peter Clemmensen, Hanno Grahn, Dominik Jarczak, Mirjam Keßler, Paulus Kirchhof, Ulf Landmesser, Susanne Lezius, Diana Lindner, Alexandre Mebazaa, Axel Nierhaus, Anil Ocak, Wolfgang Rottbauer, Christoph Sinning, Carsten Skurk, Gerold Söffker, Dirk Westermann, Antonia Zapf, Elvin Zengin, Tanja Zeller, Stefan Kluge
Publikováno v:
Karakas, M, Akin, I, Burdelski, C, Clemmensen, P, Grahn, H, Jarczak, D, Keßler, M, Kirchhof, P, Landmesser, U, Lezius, S, Lindner, D, Mebazaa, A, Nierhaus, A, Ocak, A, Rottbauer, W, Sinning, C, Skurk, C, Söffker, G, Westermann, D, Zapf, A, Zengin, E, Zeller, T & Kluge, S 2022, ' Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH) : an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial ', The Lancet Respiratory Medicine, vol. 10, no. 3, pp. 247-254 . https://doi.org/10.1016/S2213-2600(21)00439-2
Background: Cardiogenic shock has a high mortality on optimal therapy. Adrenomedullin is released during cardiogenic shock and is involved in its pathophysiological processes. This study assessed treatment with the humanised, monoclonal, non-neutrali